Dr. Larry Corey is resigning from his role as president and director of Fred Hutchinson Cancer Research Center to focus on HIV and herpes vaccine research.
Corey’s last day will be June 30. He will remain at the Hutch within the vaccine and infectious disease division and will retain the title of president and director emeritus.
“I am proud that I have accomplished the strategic goals I set when I took the job,” Corey said in a statement. “We have deepened our scientific leadership across…
Dr. Larry Corey is resigning from his role as president and director of Fred Hutchinson Cancer Research Center to focus on HIV and herpes vaccine research.
Corey’s last day will be June 30. He will remain at the Hutch within the vaccine and infectious disease division and will retain the title of president and director emeritus.
“I am proud that I have accomplished the strategic goals I set when I took the job,” Corey said in a statement. “We have deepened our scientific leadership across…